Kenneth Shain Department of Cancer Imaging and Metabolism H. Lee Moffitt Cancer Center and Research Institute Biography Publications Institution JoVE Articles Kenneth Shain has not added a biography. If you are Kenneth Shain and would like to personalize this page please email our Author Liaison for assistance. Publications A Comparison of Salvage Infusional Chemotherapy Regimens for Recurrent/refractory Multiple Myeloma Cancer. Jul, 2015 | Pubmed ID: 26149422 Evaluating Kinase ATP Uptake and Tyrosine Phosphorylation Using Multiplexed Quantification of Chemically Labeled and Post-translationally Modified Peptides Methods (San Diego, Calif.). Jun, 2015 | Pubmed ID: 25782629 An Open-label Phase I/II Study of Cyclophosphamide, Bortezomib, Pegylated Liposomal Doxorubicin, and Dexamethasone in Newly Diagnosed Myeloma European Journal of Haematology. Jan, 2015 | Pubmed ID: 25600676 A Preclinical Assay for Chemosensitivity in Multiple Myeloma Cancer Research. Jan, 2014 | Pubmed ID: 24310398 Phase II Study of Pegylated Liposomal Doxorubicin, Low-dose Dexamethasone, and Lenalidomide in Patients with Newly Diagnosed Multiple Myeloma American Journal of Hematology. Jan, 2014 | Pubmed ID: 24030918 Sequence of Novel Agents in Multiple Myeloma: an Instrumental Variable Analysis Leukemia Research. Sep, 2013 | Pubmed ID: 23809054 Stemness of B-cell Progenitors in Multiple Myeloma Bone Marrow Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Nov, 2012 | Pubmed ID: 22988056 Metastatic Myeloma? Blood. Jun, 2012 | Pubmed ID: 22700691 Bortezomib Salvage Followed by a Phase I/II Study of Bortezomib Plus High-dose Melphalan and Tandem Autologous Transplantation for Patients with Primary Resistant Myeloma British Journal of Haematology. Jun, 2012 | Pubmed ID: 22449149 Monitoring a Nuclear Factor-κB Signature of Drug Resistance in Multiple Myeloma Molecular & Cellular Proteomics : MCP. Nov, 2011 | Pubmed ID: 21846842 Clinical Outcomes of Patients with Plasma Cell Leukemia in the Era of Novel Therapies and Hematopoietic Stem Cell Transplantation Strategies: a Single-institution Experience Clinical Lymphoma, Myeloma & Leukemia. Dec, 2011 | Pubmed ID: 21813352 Environmental-mediated Drug Resistance: a Target for Multiple Myeloma Therapy Expert Review of Hematology. Dec, 2009 | Pubmed ID: 21082957 Targeting the Fanconi Anemia/BRCA Pathway Circumvents Drug Resistance in Multiple Myeloma Cancer Research. Dec, 2009 | Pubmed ID: 19934314 Beta1 Integrin Adhesion Enhances IL-6-mediated STAT3 Signaling in Myeloma Cells: Implications for Microenvironment Influence on Tumor Survival and Proliferation Cancer Research. Feb, 2009 | Pubmed ID: 19155309 Bone Marrow Stroma Confers Resistance to Apo2 Ligand/TRAIL in Multiple Myeloma in Part by Regulating C-FLIP Journal of Immunology (Baltimore, Md. : 1950). Feb, 2008 | Pubmed ID: 18209050 Stat3 Activity in Melanoma Cells Affects Migration of Immune Effector Cells and Nitric Oxide-mediated Antitumor Effects Journal of Immunology (Baltimore, Md. : 1950). Apr, 2005 | Pubmed ID: 15778348 Targeting the Bone Marrow Microenvironment in Hematologic Malignancies Seminars in Hematology. Apr, 2004 | Pubmed ID: 15190509 Regulation of the Innate and Adaptive Immune Responses by Stat-3 Signaling in Tumor Cells Nature Medicine. Jan, 2004 | Pubmed ID: 14702634 Genotypic and Phenotypic Comparisons of De Novo and Acquired Melphalan Resistance in an Isogenic Multiple Myeloma Cell Line Model Cancer Research. Nov, 2003 | Pubmed ID: 14633719 Regulation of Caspase Expression and Apoptosis by Adenomatous Polyposis Coli Cancer Research. Aug, 2003 | Pubmed ID: 12907606 Adhesion-mediated Intracellular Redistribution of C-Fas-associated Death Domain-like IL-1-converting Enzyme-like Inhibitory Protein-long Confers Resistance to CD95-induced Apoptosis in Hematopoietic Cancer Cell Lines Journal of Immunology (Baltimore, Md. : 1950). Mar, 2002 | Pubmed ID: 11859150 Multiple Myeloma: New Insights and Therapeutic Approaches Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2000 | Pubmed ID: 11701540 Un sistema organotipica High Throughput per la caratterizzazione di droga sensibilità di primaria multicampo cellule del mieloma Ariosto Silva1, Timothy Jacobson1, Mark Meads1, Allison Distler1, Kenneth Shain1 1Department of Cancer Imaging and Metabolism, H. Lee Moffitt Cancer Center and Research Institute Medicine
Un sistema organotipica High Throughput per la caratterizzazione di droga sensibilità di primaria multicampo cellule del mieloma Ariosto Silva1, Timothy Jacobson1, Mark Meads1, Allison Distler1, Kenneth Shain1 1Department of Cancer Imaging and Metabolism, H. Lee Moffitt Cancer Center and Research Institute Medicine